Do antro-duodenal manometry parameters predict clinical response after gastric peroral endoscopic pyloromyotomy in refractory gastroparesis?

IF 3.5 3区 医学 Q1 CLINICAL NEUROLOGY
Neurogastroenterology and Motility Pub Date : 2024-10-01 Epub Date: 2024-07-26 DOI:10.1111/nmo.14879
K W E Sweerts, Z Mujagic, J W A Straathof, M J M Hereijgers, D Keszthelyi, J M Conchillo
{"title":"Do antro-duodenal manometry parameters predict clinical response after gastric peroral endoscopic pyloromyotomy in refractory gastroparesis?","authors":"K W E Sweerts, Z Mujagic, J W A Straathof, M J M Hereijgers, D Keszthelyi, J M Conchillo","doi":"10.1111/nmo.14879","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Gastric peroral endoscopic pyloromyotomy (G-POEM) is a promising therapeutic modality for refractory gastroparesis (GP). However, as characteristics of suitable patients for G-POEM remain unclear, antro-duodenal manometry (ADM) has been suggested to provide objective parameters for patient selection. The aim of the present study was to identify ADM parameters as predictors for treatment response after G-POEM in refractory GP.</p><p><strong>Methods: </strong>Refractory GP patients who underwent a G-POEM between 2017 and 2022 were included. The following ADM parameters were mainly scored: antral hypomotility, pylorospasm, and the presence of neuropathic enteric patterns. Treatment response was defined as a GCSI-score decrease of ≥1 point 12 months after G-POEM. Explorative analyses were performed on potential predictors of response using logistic regression analysis.</p><p><strong>Key results: </strong>Sixty patients (52 women, mean age 52 ± 14 years.) with refractory GP (33 idiopathic, 16 diabetic, 11 postsurgical) were included. Clinical response data were available for 52 patients. In 8 out of 60 patients, it was not feasible to advance the catheter beyond the pylorus. Abnormal ADM was found in 46/60 patients (77%). Antral hypomotility and pylorospasm were found in respectively 33% and 12% of patients. At least one neuropathic enteric dysmotility pattern was found in 58% of patients. No differences were found when comparing baseline ADM parameters between clinical response groups at 12 months follow-up. Following explorative analyses, no ADM parameters were identified to predict clinical response 12 months after G-POEM.</p><p><strong>Conclusions and inferences: </strong>No ADM parameters were identified as predictors of clinical response after G-POEM in refractory GP patients. Additionally, a high percentage of abnormal ADM tracings was found, in particular with relation to enteric dysmotility, while only a low percentage of patients showed antral hypomotility or pylorospasm.</p>","PeriodicalId":19123,"journal":{"name":"Neurogastroenterology and Motility","volume":" ","pages":"e14879"},"PeriodicalIF":3.5000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurogastroenterology and Motility","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/nmo.14879","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/26 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Gastric peroral endoscopic pyloromyotomy (G-POEM) is a promising therapeutic modality for refractory gastroparesis (GP). However, as characteristics of suitable patients for G-POEM remain unclear, antro-duodenal manometry (ADM) has been suggested to provide objective parameters for patient selection. The aim of the present study was to identify ADM parameters as predictors for treatment response after G-POEM in refractory GP.

Methods: Refractory GP patients who underwent a G-POEM between 2017 and 2022 were included. The following ADM parameters were mainly scored: antral hypomotility, pylorospasm, and the presence of neuropathic enteric patterns. Treatment response was defined as a GCSI-score decrease of ≥1 point 12 months after G-POEM. Explorative analyses were performed on potential predictors of response using logistic regression analysis.

Key results: Sixty patients (52 women, mean age 52 ± 14 years.) with refractory GP (33 idiopathic, 16 diabetic, 11 postsurgical) were included. Clinical response data were available for 52 patients. In 8 out of 60 patients, it was not feasible to advance the catheter beyond the pylorus. Abnormal ADM was found in 46/60 patients (77%). Antral hypomotility and pylorospasm were found in respectively 33% and 12% of patients. At least one neuropathic enteric dysmotility pattern was found in 58% of patients. No differences were found when comparing baseline ADM parameters between clinical response groups at 12 months follow-up. Following explorative analyses, no ADM parameters were identified to predict clinical response 12 months after G-POEM.

Conclusions and inferences: No ADM parameters were identified as predictors of clinical response after G-POEM in refractory GP patients. Additionally, a high percentage of abnormal ADM tracings was found, in particular with relation to enteric dysmotility, while only a low percentage of patients showed antral hypomotility or pylorospasm.

胃十二指肠测压参数能否预测难治性胃瘫患者经胃内镜幽门切开术后的临床反应?
背景:胃经口内镜幽门切开术(G-POEM)是治疗难治性胃瘫(GP)的一种很有前景的方法。然而,由于适合 G-POEM 的患者特征仍不明确,因此有人建议使用反十二指肠测压法(ADM)为患者选择提供客观参数。本研究旨在确定 ADM 参数,作为难治性 GP 患者接受 G-POEM 治疗后治疗反应的预测指标:纳入2017年至2022年间接受G-POEM的难治性GP患者。主要对以下 ADM 参数进行评分:前胃蠕动减弱、幽门痉挛和是否存在神经性肠道模式。治疗反应定义为 G-POEM 治疗 12 个月后 GCSI 评分下降≥1 分。利用逻辑回归分析对反应的潜在预测因素进行了探索性分析:共纳入 60 名难治性 GP 患者(52 名女性,平均年龄为 52 ± 14 岁)(33 名特发性患者,16 名糖尿病患者,11 名手术后患者)。52 名患者有临床反应数据。60 例患者中有 8 例无法将导管推进到幽门以外。在 46/60 例患者(77%)中发现 ADM 异常。分别有 33% 和 12% 的患者发现前胃运动减弱和幽门痉挛。58% 的患者至少发现一种神经性肠道运动障碍模式。在随访 12 个月时,比较临床反应组之间的 ADM 基线参数未发现差异。经过探索性分析,没有发现 ADM 参数可预测 G-POEM 12 个月后的临床反应:结论和推论:在难治性GP患者接受G-POEM治疗后,未发现任何ADM参数可预测临床反应。结论和推论:在难治性 GP 患者中,未发现 ADM 参数可预测 G-POEM 后的临床反应。此外,发现 ADM 曲线异常的比例较高,尤其是与肠道运动障碍有关的异常,而只有较低比例的患者表现为前胃运动功能减退或幽门痉挛。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neurogastroenterology and Motility
Neurogastroenterology and Motility 医学-临床神经学
CiteScore
7.80
自引率
8.60%
发文量
178
审稿时长
3-6 weeks
期刊介绍: Neurogastroenterology & Motility (NMO) is the official Journal of the European Society of Neurogastroenterology & Motility (ESNM) and the American Neurogastroenterology and Motility Society (ANMS). It is edited by James Galligan, Albert Bredenoord, and Stephen Vanner. The editorial and peer review process is independent of the societies affiliated to the journal and publisher: Neither the ANMS, the ESNM or the Publisher have editorial decision-making power. Whenever these are relevant to the content being considered or published, the editors, journal management committee and editorial board declare their interests and affiliations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信